Kymera Therapeutics, Inc. (KYMR) Financials

NASDAQ Currency in USD Disclaimer

$40.82

north_east $0.03 (0.07%)
Day's range
$40.14
Day's range
$41.71

KYMR Income statement / Annual

Last year (2023), Kymera Therapeutics, Inc.'s total revenue was $78.59 M, an increase of 67.84% from the previous year. In 2023, Kymera Therapeutics, Inc.'s net income was -$146.96 M. See Kymera Therapeutics, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $78.59 M $46.83 M $72.83 M $34.03 M $2.93 M $0.00
Cost of Revenue $189.08 M $2.98 M $2.40 M $62.11 M $825,000.00 $205,000.00
Gross Profit -$110.49 M $43.85 M $70.44 M -$28.07 M $2.11 M -$205,000.00
Gross Profit Ratio -1.41 0.94 0.97 -0.82 0.72 0
Research and Development Expenses $189.08 M $164.25 M $137.02 M $62.11 M $37.16 M $17.68 M
General & Administrative Expenses $55.04 M $43.83 M $36.35 M $18.23 M $7.98 M $3.77 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $55.04 M $43.83 M $36.35 M $18.23 M $7.98 M $3.77 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $244.12 M $208.08 M $173.36 M $80.34 M $45.14 M $21.45 M
Cost And Expenses $244.12 M $208.08 M $173.36 M $80.34 M $45.14 M $21.45 M
Interest Income $18.76 M $6.62 M $488,000.00 $826,000.00 $1.01 M $0.00
Interest Expense $196,000.00 $176,000.00 $175,000.00 $115,000.00 $46,000.00 $16,000.00
Depreciation & Amortization $3.57 M $2.98 M $2.40 M $1.76 M $825,000.00 $205,000.00
EBITDA -$143.20 M -$151.66 M -$97.65 M -$43.72 M -$40.38 M -$21.25 M
EBITDA Ratio -1.82 -3.3 -1.37 -1.34 -13.76 0
Operating Income Ratio -2.11 -3.44 -1.38 -1.36 -14.38 0
Total Other Income/Expenses Net $18.57 M $6.45 M $313,000.00 $711,000.00 $959,000.00 -$16,000.00
Income Before Tax -$146.96 M -$154.81 M -$100.22 M -$45.59 M -$41.25 M -$21.47 M
Income Before Tax Ratio -1.87 -3.31 -1.38 -1.34 -14.06 0
Income Tax Expense $0.00 -$2.98 M -$2.22 M -$1.65 M $46,000.00 $43,859.00
Net Income -$146.96 M -$151.83 M -$98.00 M -$43.95 M -$41.29 M -$21.47 M
Net Income Ratio -1.87 -3.24 -1.35 -1.29 -14.07 0
EPS -2.52 -2.82 -2.04 -2.53 -0.93 -0.48
EPS Diluted -2.52 -2.82 -2.04 -2.53 -0.93 -0.48
Weighted Average Shares Out $58.37 M $53.93 M $47.99 M $17.35 M $44.53 M $44.53 M
Weighted Average Shares Out Diluted $58.37 M $53.93 M $47.99 M $17.35 M $44.53 M $44.53 M
Link